NCT01962831

Brief Summary

The purpose of this study is to compare the efficacy of single balloon foley catheters to dinoprostone for the induction of labour of obese women. The investigators suspect that women assigned to the foley group will have a shorter induction to delivery time than women in the dinoprostone group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Oct 2013

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 19, 2013

Completed
12 days until next milestone

Study Start

First participant enrolled

October 1, 2013

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 14, 2013

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

October 13, 2016

Status Verified

October 1, 2016

Enrollment Period

2.7 years

First QC Date

September 19, 2013

Last Update Submit

October 12, 2016

Conditions

Keywords

obesitylabor, inducedpregnancycervical ripeningdinoprostone

Outcome Measures

Primary Outcomes (1)

  • Time(hours) from initiation of induction of labour to vaginal delivery

    Will be assessed at the end of each vaginal delivery

Secondary Outcomes (9)

  • Number of vaginal deliveries within 24 hours in each group

    2 years

  • Number of cesarean sections in each group

    2 years

  • Number of operative vaginal deliveries in each group

    2 years

  • Number of chorioamnionitis cases in each group

    2 years

  • Number of patients that required oxytocin administration in each group

    2 years

  • +4 more secondary outcomes

Study Arms (2)

dinoprostone

EXPERIMENTAL

Group of women that will receive dinoprostone for induction of labour dinoprostone 10 mg in vagina to be reassessed every 24 hours

Drug: Dinoprostone

Single balloon foley catheter

EXPERIMENTAL

Group of women that will have a single balloon foley catheter inserted for induction of labour

Device: Single balloon foley catheter

Interventions

Also known as: Cervidil
dinoprostone
Single balloon foley catheter

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Obese (BMI \>30 before 20 weeks gestational age)
  • Singleton pregnancy
  • Vertex presentation
  • Bishop Score \<6
  • Intact membranes
  • Gestational age 37+0 to 42+0
  • Normal fetal heart tracing on admission for ripening

You may not qualify if:

  • Induction of labour for intrauterine fetal demise
  • Intrauterine growth restriction
  • Suspected abruption at the start of induction
  • Any contraindication for a vaginal delivery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Regina Qu'Appelle Health Region

Regina, Saskatchewan, S4P0W5, Canada

Location

MeSH Terms

Conditions

Obesity

Interventions

Dinoprostone

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Prostaglandins EProstaglandinsEicosanoidsFatty Acids, UnsaturatedFatty AcidsLipidsAutacoidsInflammation MediatorsBiological Factors

Study Officials

  • Christine Lett, MD

    Saskatchewan Health Authority - Regina Area

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor of Obstetrics & Gynecology, University of Saskatchewan

Study Record Dates

First Submitted

September 19, 2013

First Posted

October 14, 2013

Study Start

October 1, 2013

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

October 13, 2016

Record last verified: 2016-10

Locations